Vol. 178, No. 1, 1991 July 15, 1991
BIOCHEMICAL
CHARACTERIZATION
OF PORPHY
AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 336-342
ROMONAS
HEMAGGLUTININ
Makoto ICentral Sapporo
Received
May
Nishikatal
(~ACTEROIDES)
GINGIVALIS
AS A PROTEASE
and Fuminobu
Yoshimura2
Research Division, School of Dentistry, Hokkaido University, 060 and *Department of Microbiology, School of Dentistry, Aichi-Gakuin University, Nagoya 464, Japan
23,
1991
A hemagglutinin (HA) was purified to homogeneity from the membrane fraction of the oral bacterium Porphyromonas gingivalis. The HA possessed protease activity hydrolyzing proteins and arginine-containing synthetic subby thiol-blocking reagents, and The protease activity was inhibited strates. The HA functions as hence the HA can be characterized as a cystein protease. an attachment factor and its substrate-binding site is responsible for the attachment to an erythrocyte. B 1991 Academic Press, Inc.
Porphyromonas unique but
hemagglutinin is
valis
by
antipain
and
inhibited HA
fraction
by and
participates have
and
leupeptin. protease
a purified
to
which,
is
inhibited
that
the
direct
lectins,
that by
binding therefore
binding
periodontal is
pathogen not
arginine-containing
demonstrated
activities
obtain
putative unlike
and
We
in erythrocyte
attempted
by using
(4)
TLCK,
a
arginine
investigation membrane
both
(HA)
inhibited
previous
is
gingivalis,
and
peptides
of
inhibitors
the
bacterial
speculated
that and
evidence
inhibited
hemagglutination
protease
the
that
that
same
substrate p.
(l),
site
by
sugars
(2,3).
Our
by
the
such
as
cells
to
the
1.
gingi-
leupeptin,
erythrocytes
E, gingivalis of
has
HA
HA
has
molecule
binding.
In this
study,
gingivalis
HA
a protease
is
we
HA preparation.
Abbreviations: HA, hemagglutinin; 2-ME, 2-mercaptoethanol; SDS, sodium dodecyl sulfate; PAGE, polyacrylamide gel electrophoresis; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-l-propanesulfonate; TLCK, Tos-Lys chloromethyl ketone; ALCK; AC-Lys chloromethyl ketone: Bz, benzoyl; Z, benzyloxycarbonyl; Boc, tbutyloxycarbonyl; Tos, tosyl; AC, acetyl; pNA, e-nitroanilide; MCA, 4-methylcoumaryl-7-amide. OOCS291W91
Copyright All rights
$1.50
0 1991 by Academic Press, Inc. of reproduction in any form reserved.
336
Vol.
BIOCHEMICAL
178, No. 1, 1991
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
METHODS Assay of HA: Serially twofold-diluted samples in trisodium citrate and 0.15 M NaCI, pH 7.5) containing with an equal volume of 0.5% (v/v) chicken erythrocyte a titer plate with U-bottom wells. The mixture was at room temperature. The titer was expressed as the dilution showing hemagglutination.
0.5 ml of SSC (15 mM 4 mM 2-ME were mixed suspension in SSC using left standing for 90 min reciprocal of the highest
Assay of Protease: Unless otherwise stated, protease activity was assayed with Bz-Arg-pNA as the substrate. A sample was mixed with 1 ml of 50 mM Tris-HCI (pH 8.5) containing 50 mM 2-ME and 0.2 mM Bz-Arg-pNA. After an appropriate incubation time at 25OC, 0.2 ml of 50% acetic acid was added and the increase in absorbance at 410 nm was measured. Purification of HA: The membrane fraction (wet) of E. gingivalis 381 prepared as described previously (5) was homogenized with a Teflon-pestle homogenizer in 50 volumes of 20 mM phosphate buffer (pH 7.3) containing 1% CHAPS, 25 mM 2-ME and 5 mM methylguanidine. The homogenate was incubated for 2 h at 40°C to effect solubilization and centrifuged at 110,000 x g for lh. After the supernatant had been incubated for 30 h at 40°C to dissociate HA aggregates, HA was purified from this supernatant (10 ml) by sequential steps of chromatography consisting of Bio-Gel A-0.5m (Bio-Rad) gel filtration (Fig. lA), DE-52 (Whatman) ion-exchange chromatography (Fig. 1B) and arginine-cellulose affinity chromatography (Fig. 1 C). The affinity adsorbent was prepared by coupling of arginine methyl ester with CM-52 (Whatman) using a water-soluble carbodiimide followed by trypsrn treatment for the removal of the methoxy group.
RESULTS Purity cellulose ular
of HA:
affinity
mass
SDS-PAGE
column
of 44 kDa
of the
(Fig.
under
HA
1C)
gave
reduced
and
preparation
a single
obtained
band
non-reduced
from
with (not
an
an arginine-
apparent
shown)
molec-
conditions
(Fig.
2). Attempt Fig.
1C shows,
lyzing of
the
HA To
Bio-Gel
A-0.5m
ciative
synthesis
could
protease
activity
was
accompanied
learn
whether in
in the
conditions.
The
properties
presence
tried
to HA
irreversible this
activities:
As the
by the
protease
purified
HA
from also
failed
separate
the
preparation
was
protease
compound 337
will
(Fig.
due the
3).
The
to separate two
published
with
a trace prepara-
HA
and
filtration the
activities
treated
HA
of hydro-
to
Gel
other.
inhibitor be
activity
was
preparation,
each
chromatogram
protease
activity
of CHAPS
separated
purified
of
the
of CHAPS
we
site-directed and
be
presence
Next,
the
in the not
shown).
active
and
by PAGE
activities
(not
HA
protease
was analyzed
protease
itie
separate
Bz-Arg-pNA.
contaminating
tion
tive
to
the on
two
activ-
under
disso-
the
[AC-3HlALCK elsewhere)
radioac(the and
Vol.
BIOCHEMICAL
178, No. 1, 1991
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
u Purification of P. gingivalis HA. (A) Gel filtration on a Bto-Gel A-0.5m column (3.1 x 74-cm). (B) Ion-exchange chromatography on a DE-52 column (1.0 x 6.4 cm). (C) Affinity chromatography on an arginine-cellulose column (1.0 x 6.4 cm). Elution buffer: (A) 20 mM phosphate buffer (pH 7.3)/ 0.1% CHAPS/25 mM 2-ME/l mM methylguanidine; (B and C) the same as in A except that methylguanidine was excluded. Fraction volume: (A) 20 ml; (B and C) 4 ml. All chromatography steps were done at 4OC. Fractions were assayed for HA activity, protease activity (lo-p1 aliquot, IO-min incubation) and protein content (estimated from fluorescence of tryptophan). Fractions pooled are indicated by the bar. The first HA peak in A seemed to contain aggregates and therefore was not fractionated further.
subjected
to
stained
band
urement
of
taining
3%
SDS-PAGE.
As
were
detected
excised
fractions
Protosol
rated
exclusively
strate
that
the
and the protease
Fig. at
the
of
(DuPont-NEN)
into
the
4 shows, same
the
position.
stained
gel
confirmed
stained
protease
activity
is
activities
are exhibited
and
radioactivity
that
Direct suspended the
band
(not
shown).
not
due
to
by the same 338
a Coomassie radioactivity in
radioactivity
These
contamination,
molecule.
bluemeas-
Econofluor was
resu I ts i.e.,
conincorpo-
demonthe
HA
Vol.
178,
No.
BIOCHEMICAL
1, 1991
AND
COMMUNICATIONS
kDe 66-e
i
*i
45Jo-
02
RESEARCH
r=
kDa 94BB-
BIOPHYSICAL
HA
Protsase
I
0
SDS-PAGE of buffer system with 5% 2-ME.
1)
30-
I I I 1I 1’ ’
Act.
BPB-
FicLz. Laemmli reduced
45--.
Act.
(A,,,)
purified HA. The electrophoresis (10) in 12.5% polyacrylamide The gel was silver-stained.
E&J-.& PAGE of purified HA. The using the Davis buffer system (11) presence of 0.6% CHAPS. One lane R-250. The other was excised (5 mm) a spatula in 0.5 ml of 50 mM Tris-HCI incubation of the suspension at 4OC assayed for HA activity and the whole tease activity (30-min incubation).
0.1
slab
a
0 4
was performed gel. The
using sample
the was
electrophoresis was performed in duplicate in 5% polyacrylamide slab gel in the was starned with Coomassie brilliant blue and each gel fraction was pulverized with (pH 8.5) containing 50 mM 2-ME, After for 18 h, the supernatant (100 ul) was of the remainder was assayed for pro-
Fia. 4. SDS-PAGE of [Ac-3H]ALCK-treated HA. The purified HA, after removal of methylguanldine by dialysis, was incubated with 50 uM [AC-~H]ALCK at 25OC for 30 min in 20 mM phosphate buffer (DH 7.3) containina 0.5% CHAPS and 1 mM The incubation inactivated protease activity by 94%. The reaction mix2-ME. ture was dialyzed against dilute HCI and tyophilyzed. SDS-PAGE was performed One lane was stained with Coomassie blue (a) and in duplicate as in Fig. 2. the other was subjected to fluorography (b).
Effects protease est
of
99%
at
0.1
it
by
81%
though
protease
inhibitors
ethylmaleimide
of
the
the the 0.04
Salmine
FM.
activities,
amino
compounds
with
and
Benzamidine,
enzyme
Of inhibited
(measured
activity +O.
Various
activities.
inhibitor:
by
inhibitors:
the
activity
protease
much
more
TLCK and
inhibitor
(7)
after
activity
by
and
ALCK,
other
two
activities
than
arginine by
TLCK
at
and
The
iodoacetamide
and
was
the
investigated
339
was
either with
the
pg/ml
activity at
0.2
HA -
inhibited
0.4 both
irreversible reagents
activities.
The
inhibitory.
Sugars
activity. various
25OC)
the
(roughly also
and
strong-
inhibited
thiol-blocking
not
HA
protease
site-directed
both
inhibit
the
preincubation
arginine
the
was not
2
active
inactivated
did
and lo-min
69%
agmatin weakly.
(6)
polypeptide,
diisopropylfluorophosphate
acids
98%
arginine-rrch
methylguanidine,
both
leupeptin
by
Bz-Arg-pNA an
inhibited
examined,
HA
mM
sulfate,
compounds
iserine
Inactivation TLCK
concentra-
and
b
Vol.
178,
No.
1, 1991
BIOCHEMICAL
AND
BIOPHYSICAL
TLCK Fia. 5. Inactivation purified HA, after TLCK at 25OC for and 5 mM 2-ME. bly, TLCK reacted
As
tions.
Fig.
increasing
5
TLCK
least
the
the
tin
to
of
a
HA
these
in in
the
the
protease
37OC
with
found
to functrons
the
sole
site
as for
investigated
substrate
to
an
the
hydrolyzed (Bz-Arg-OC2H8)
100
80%
FM)
could
and of
HA
and
can
be
or
at
was wells
the
leupepof
the
(&fold inhib-
showed was
(6-day
total
its
of
strongly
that
negative chosen
and
incubation
protease
findings
that
detected
hemagglutination
measured of
be
resuspension
concentration
These
factor
HA
Addition
the
was
erythrocytes.
at
activity
demonstrate
was that
substrate-binding
the
site
is
attachment.
substrates
small
activity
From
About
the
with
activity,
hemagglutination
highest
parallel
hemagglutination.
collapse
supernatant
attachment
erythrocyte
with HA
the
the
leupeptin.
Bz-Arg-pNA).
of
of
The with CHAPS Proba-
in
catalytic
protease
above,
with
its
that
hemagglutination.
in
uM
well
unattached
Hydrolysis
ester
0.1
in
mM
No
concentration
of
indicate
that for
showing
described
decreased
results
is essential
wells
As
activity
activities
and
resulted
the
be
HA
the
the
(final
presence
0.5
two
protease site,
titer).
hemagglutination,
1,
cystein
of wells
(nM)
These
erythrocytes
decrease
the
in hemagglutination:
supernatant
agglutinated
ited
shows,
substrate-binding
Role in
clearly
as
COMMUNICATIONS
of HA (0) and protease (0) activities by TLCK. removal of methylguanidine by dialysis, was incubated 1 h in 20 mM phosphate buffer (pH 7.3) containing 0.5% Longer incubation did not cause further inactivation. with 2-ME as well as with the HA.
concentrations.
characterized
RESEARCH
by HA:
synthetic only
The
substrates
those was
synthetic hydrolyzed
340
catalytic and
properties proteins.
substrates much
of As
containing more
slowly
the
shown
HA
were
in
Table
arglnine. than
The the
amide
Vol.
178,
No.
1, 1991
BIOCHEMICAL
Table
1.
Hydrolysis
AND
BIOPHYSICAL
of synthetic
RESEARCH
substrates
Substrate
by purified
Hydrolysis
Bz-Arg-pNA Z-Arg-pNA Bz-Arg-MCA Tos-Gly-Pro-Arg-pNA Bz-Arg-OC2H5
COMMUNICATIONS
HA
rate
100 45 111 155 1.6
Hydrolysis not observed: glutaryl-Phe-pNA, Bz-Tyr-pNA, succinyl-(Alafg-pNA, Z-Gly-Pro-pNA, Bz-DL-Lys-pNA (0.08 mM), Tos-Gly-Pro-Lys-pNA, Boc-Val-Leu-Lys-MCA Substrates (0.04 mM) were incubated with the purified HA at 25OC in 50 Tris-HCI (pH 8.5) containing 50 mM 2-ME. Hydrolysis was followed by continuous monitoring of the change of absorbance at 410 nm (e-nitroanilide), 370 nm (4-methylcoumaryl-7-amide) and 253 nm (Bz-Arg-OC2H5). The rate of Arg-pNA hydrolysis was assumed to be 100.
substrates.
Proteins
bovine
such
fibrinogen
hydrolysates
were
(not
as
also
bovine
serum
hydrolyzed
albumin,
as
chicken
demonstrated
mM the Bz-
ovalbumin
by
and
SDS-PAGE
of
the
shown).
DISCUSSION In -lis
this
381
work
and
we
found
it
arginine-containing lation This
(4).
Vibrio
HA,
a
is
cytes
via
a its
The
(nii)
treatment loss
the of
of
of the
culture
and
the
to
is
hydrolyzes with
as
supernatant
a
per
is
di-
by
(i)
arginine
lnoshita
contact of
residue 1.
gingivalis
341
in
to
erythro-
results
to
et between 381.
al.
(2)
and
related
erythrocytes It
is
to com-
and an
the
binds
(iv)
appreciable
suggested and
not
deter-
with HA
also
or
be
the
in
con-
multimeric,
substrates,
deiminase
of
HA,
interacts
because
inhibited
or
remains
specifically
arginine,
arginine
characteristics
factor
molecule
specuactivity.
Our
arginine-containing
(unpublished).
arginine
surface
HA
and
protease
attachment the
gingiva-
previous
(8).
an
that
be
with
change
Whether
erythrocyte
HA
erythrocytes
as
site
seems
HA
f.
proteins
our
autoaggregate
serves
of
hydrolyze
confirmed
to
to
fraction
to
an
assumed
them
an
HA
agglutinability
importance from
(ii)
able
produces
site.
on
arginine-cellulose, pounds,
is
membrane
which
substrate-binding
site
the
protease
also
protease
residue
substrate-binding
from
substrates,
allowing
one
HA a
substrate-binding
than
mined.
be
metalloprotease,
cystein
more
an
cholerae
thereby
trast,
to
synthetic
erythrocytes,
has
purified
known
the
their whether
HA
Vol.
178, No. 1, 1991
our
HA
for
hemagglutination.
HA
wrth
hydrolyzes
erythrocyte This
reagents
cyte-binding
of p.
BIOCHEMICAL
that
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
proteins should
be
inactivate
or
peptides
verified
protease
as a prerequisite
by chemical activity
action
modification
without
altering
of
the
erythro-
ability.
Recently,
Li
et
gingivalis
to
Actinomvces
It is possible
that
al.
the
(9)
HA
viscosus obtained
activity-possessing
HAS
part,
of the two
in the cohesion
in
demonstrated
partial by
in the
protease
of
inhibitors
present if
_P. gingivalis,
inhibition
work
any,
and
the
adherence
such
as TLCK.
other
protease
participate,
at
least
in
bacteria.
ACKNOWLEDGMENTS
This from
the
work Ministry
and the Akiyama
was of
supported Education,
in part
by
Science
Grants-in-Aid and
for
Culture
of
Scientific
Japan
(No.
Research 63570865)
Foundation. REFERENCES
1. 2. 3. 4. 5. 6. 7.
Slots, J., Bragd, L., Wikstrom, M., and Dahlen, G. (1986) J. Clan. Per iodontol. 13, 570-577. lnoshita, E., Amano, A., Hanioka, T., Tamagawa, H., Shizukuishj, S., and Tsunemitsu, A. (1986) Infect. Immun. 52, 421-427. Okuda, K., Yamamoto, A., Naito, Y., Takazoe, I., Slots, J., and Genco, R.J. (1986) Infect. Immun. 54, 659-665. Nishikata, M., Yoshimura, F., and Nodasaka, Y. (1989) Microbial. Immunol. 33, 75-78. Yoshimura, F., Nishikata, M., Suzuki, T., Hoover, C.I., and Newbrun, E. (1984) Archs Oral Biol. 29, 559-564. Aoyagi, T., Miyata, S., Nanbo, M., Kojima, F., Matsuzaki, M., Ishizuka, M., Takeuchi, T., and Umezawa, H. (1969) J. Antibiotics 22, 558-568. Shaw, E., Mares-Guia, M., and Cohen, W. (1965) Biochemrstry 4, 221g2224.
8.
9.
Booth, B.A., Sciortino, C.V., and Finkelstein, Lectins and Agglutinins (D. Mirelman, Ed.), Sons, Inc., New York. Li, J Ellen, R.P., Hoover, C.I., and Felton, 70,
10. 11.
R.A. (1986) In Microbial pp.169-182. John Wiley J.R.
85186.
Laemmli, V.K. (1970) Nature Davis, B.J. (1964) Ann. N.Y.
227, 680-685. Acad. Sci. 121, 404-427.
342
(1991)
J.
Dent.
&
Res.